Еврооблигации: Amgen, 3.15% 21feb2040, USD (WKN A28T14)
Trace-eligible, Senior Unsecured
Trace-eligible, Senior Unsecured
Откройте глобальную базу данных
1 000 000
облигаций
80 234
акций
168 394
ETF & Funds
80 000
индексов
Отслеживайте свой портфель наиболее эффективным способом
|
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel ...
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
|
|
|
|
|
|
|
|
|
Откройте глобальную базу данных
1 000 000
облигаций
80 234
акций
168 394
ETF & Funds
80 000
индексов
Отслеживайте свой портфель наиболее эффективным способом
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |